4//SEC Filing
Davis Andrew 4
Accession 0000950170-24-029910
CIK 0001446847other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:05 PM ET
Size
7.3 KB
Accession
0000950170-24-029910
Insider Transaction Report
Form 4
Davis Andrew
SVP, Chief Business Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-03-08+37,120→ 310,756 total - Exercise/Conversion
Performance-based Restricted Stock Unit
2024-03-08−37,120→ 0 totalExp: 2026-02-28→ Class A Common Stock (37,120 underlying)
Footnotes (3)
- [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024.
- [F2]Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share.
- [F3]Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001932525
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:05 PM ET
- Size
- 7.3 KB